Vnitr Lek 2016, 62(10):770-772

Magnetická rezonance u kardiomyopatií - editorial

Pavel Gregor
Kardiocentrum - III. interní-kardiologická klinika 3. LF UK a FN Královské Vinohrady, Praha

Received: June 24, 2016; Published: October 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregor P. Magnetická rezonance u kardiomyopatií - editorial. Vnitr Lek. 2016;62(10):770-772.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fikrle M et al. Přínos magnetické rezonance pro diagnostiku kardiomyopatií a myokarditidy. Vnitř Lék 2016; 62(10): 795-803. Go to PubMed...
    2. Deux JF, Damy T, Rahmouni A et al. Noninvasive detection of cardiac invovement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance paging: a prospective study. Amyloid 2014; 21(4): 246-255. Dostupné z DOI: <http://dx.doi.org/10.3109/13506129.2014.956924>. Go to original source... Go to PubMed...
    3. Tummala LS, Young RK, Singh T et al. Role of non-invasive imaging in the work-up of cardiomyopathies. Curr Atheroscler Rep 2015; 17(3): 486. Dostupné z DOI: <http://dx.doi.org/10.1007/s11883-014-0486-1>. Go to original source... Go to PubMed...
    4. Limongelli G, Rea A, Masarone D et al. Tight ventricular cardiomyopathies: a multidisciplinary approach to diagnosis. Echocardiography 2015; 32(Suppl 1): S75-S94. Dostupné z DOI: <http://dx.doi.org/10.1111/echo.12399>. Go to original source... Go to PubMed...
    5. Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proper modification of the task force criteria. Circulation 2010; 121(13): 1533-1541. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.108.840827>. Go to original source... Go to PubMed...
    6. Maron BJ, Ommen SR, Semsarian Ch et al. Hypertrophic cardiomyopathy. Present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 2014; 64(1): 83-99. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2014.05.003>. Erratum in J Am Coll Cardiol 2014; 64(11):1188. Go to original source... Go to PubMed...
    7. Kebed KY, Al Adham RI, Bishu K et al. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI. Int J Cardiovasc Imaging 2014; 30(3): 591-597. Dostupné z DOI: <http://dx.doi.org/10.1007/s10554-013-0355-y>. Go to original source... Go to PubMed...
    8. Gunaratnam K, Wong LH, Nasis A et al. Review of cardiomyopathy imaging. Eur J Radiol 2013; 82(10): 1763-1775. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ejrad.2013.05.041>. Go to original source... Go to PubMed...
    9. Blankstein R, Rowin EJ. What is the best paging test for patients with hypertrophic cardiomyopathy it depends on the clinical question. J Cardiovas Comput Tomography 2014; 8(6): 438-441. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jcct.2014.10.003>. Go to original source... Go to PubMed...
    10. Baxa J, Ferda J, Rokyta R et al. The role of cardiovascular contrast magnetic resonance in assessment of acute myocarditis. Ces Radiol 2009; 63(1): 13-19.
    11. Kubánek M, Voska L. Giant cell myocarditis and cardiac sarcoidosis - update 2015. Kardiol Rev Int Med 2015; 17(4): 295-299.
    12. Grigoratos C, Bratis K, Henningsson M et al. Chemotherapy-related cardiomyopathy in acute myeloid leukaemia assessed by cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2015; 15(12): 1410. Dostupné z DOI: <http://dx.doi.org/10.1093/ehjci/jeu150>. Go to original source... Go to PubMed...
    13. Grothoff M, Pachowsky M, Hoffmann J et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol 2012; 22(12): 2699-2709. Dostupné z DOI: <http://dx.doi.org/10.1007/s00330-012-2554-7>. Go to original source... Go to PubMed...
    14. Bossone E, Lyon A, Citro R et al. Takotsubo cardiomyopathy: an integrated multi-imaging approach. Eur Heart J Cardiovasc Imaging 2014; 15(4): 366-377. Dostupné z DOI: <http://dx.doi.org/10.1093/ehjci/jet167>. Go to original source... Go to PubMed...
    15. Chan RH, Maron BJ, Olivoto I et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden dech risk in patients with hypertrophic cardiomyopathy. Circulation 2014; 130(): 484-495. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007094>. Go to original source... Go to PubMed...
    16. Yamada T, Hirashiki A, Okumura T et al. Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. J Card Fail 2014; 20(11): 825-832. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cardfail.2014.08.005>. Go to original source... Go to PubMed...
    17. Ghosh N, Kwong RY. It's time to study cardiac magnetic resonance imaging as strategic tool in nonischemic cardiomyopathy. Circ Heart Fail 2014; 7(3): 391-393. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCHEARTFAILURE.114.001309>. Go to original source... Go to PubMed...
    18. Masci PG, Doulaptsis C, Bertella E et al. Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure. Circ Heart Fail 2014; 7(3): 448-456. Dostupné z DOI: <http://dx.doi.org/10.1161/CIRCHEARTFAILURE.113.000996>. Go to original source... Go to PubMed...
    19. Doesch C, Dierks DM, Haghi D et al. Right ventricular dysfunction, late gadolinium enhancement, and fiale tender predict poor outcome in patients with dilated cardiomyopathy. Int J Cardiol 2014; 177(2): 429-435. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2014.09.004>. Go to original source... Go to PubMed...
    20. Nabeta T, Inomata T, Iida Y et al. Baseline cardiac magnetic resonance paging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy. Heart Vessels 2014; 29(6): 784-792. Dostupné z DOI: <http://dx.doi.org/10.1007/s00380-013-0415-1>. Go to original source... Go to PubMed...
    21. Barone-Rochette G, Augier C, Rodiere M et al. Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis. J Magn Reson Imaging 2014; 40(6): 1347-1354. Dostupné z DOI: <http://dx.doi.org/10.1002/jmri.24504>. Go to original source... Go to PubMed...
    22. Liu GY, Yang X, Su Y et al. Cardiovascular magnetic resonance imaging findings in children with myocarditis. Chin Med J (Engl) 2014; 127(21): 3700-3705. Go to original source... Go to PubMed...
    23. Ashrith G, Gupta D, Hanmer J et al. Cardiovascular magnetic resonance characterization of left ventricular non-compaction provides independent prognostic information in patients with incident heart failure or suspected cardiomyopathy. Journal of Magnetic Resonance 2014; 16: 64. Dostupné z DOI: <http://dx.doi.org/10.1186/s12968-014-0064-2>. Go to original source... Go to PubMed...
    24. Hen Y, Iguchi N, Utanohara Y et al. Prognostic value of late gadolinium enhancement on cardiac magnetic resonance paging in japanese hypertrophic cardiomyopathy patients. Circ J 2014; 78(4): 929-937. Go to original source... Go to PubMed...
    25. Todiere G, Aquaro D, Piaggi P et al. Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2012; 60(10): 922-929. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2012.03.076>. Go to original source... Go to PubMed...
    26. Hoey ETD, Teoh JK, Das I et al. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy. Clin Radiol 2014; 69(3): 221-230. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crad.2013.11.012>. Go to original source... Go to PubMed...
    27. Hanneman K, Crean AM, Williams L et al. Cardiac magnetic resonance imaging findings predict major averse events in apical hypertrophic cardiomyopathy. J Thorac Imaging 2014; 29(6): 331-339. Dostupné z DOI: <http://dx.doi.org/10.1097/RTI.0000000000000115>. Go to original source... Go to PubMed...
    28. Smith BM, Dorfman AL, Yu SK et al. Clinical signifikance of late gadolinium enhancement in patients < 20 years of age with hypertrophic cardiomyopathy. Am J Cardiol 2014; 113(7): 1234-1239. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjcard.2013.12.034>. Go to original source... Go to PubMed...
    29. Amano Y, Kitamura M, Tachi M et al. Delayed enhancement magnetic resonance imaging in hypertrophic cardiomyopathy with basal septal hypertrophy and preserved ejection fiction : relationship with ventricular tachyarrhythmia. J Comput Assist Tomogr 2014; 38(1): 67-71. Dostupné z DOI: <http://dx.doi.org/10.1097/RCT.0b013e3182a2fb01>. Go to original source... Go to PubMed...
    30. Leonardi S, Raineri C, DeFerrari GM et al. Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and suden deth in patients with hypertrophic cardiomyopathy. Eur Heart J 2009; 30(16): 2003-2010. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehp152>. Go to original source... Go to PubMed...
    31. Bruder O, Wagner A, Jensen CJ et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major averse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56(11): 875-887. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2010.05.007>. Go to original source... Go to PubMed...
    32. Magri D, De Cecco CN, Piccirillo G et al. Myocardial repolarization dispersion and late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Circ J 2014; 78(5): 1216-1223. Go to original source... Go to PubMed...
    33. Yamazava H, Takeda A, Takei K et al. Primary preventiv of sudden cardiac dech in a low-risk child with familial hypertrophic cardiomyopathy : the role of cardiac magnetic resonance imaging. Clin Res Cardiol 2014; 103(1): 75-77. Dostupné z DOI: <http://dx.doi.org/10.1007/s00392-013-0631-9>. Go to original source... Go to PubMed...
    34. Kallianos K, Moraes GL, Ordovas KG. Prognostic role of MR imaging in nonischemic myocardial disease. Magn Reson Imaging Clin N Am 2015; 23(1): 89-94. Dostupné z DOI: <http://dx.doi.org/10.1016/j.mric.2014.09.004>. Go to original source... Go to PubMed...
    35. Clayton B, Roobottom C, Morgan-Hughes M. Assessment of the myocardium with cardiac computed tomography. Eur Heart J Cardiovasc Imaging 2014; 15(6): 603-609. Dostupné z DOI: <http://dx.doi.org/10.1093/ehjci/jeu028>. Go to original source... Go to PubMed...
    36. Zhao L, Ma X, Feuchtner GM et al. Quantification of myocardial delayed enhancement and wall thickness in hypertrophic cardiomyopathy: multidetector computed tomography versus magnetic resonance imaging. Eur J Radiol 2014; 83(10): 1778-1785. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ejrad.2014.05.035>. Go to original source... Go to PubMed...
    37. Valsangiacomo Buechel ER, Grosse-Wortmann L, Fratz S et al. Indications for cardiovascular magnetic resonance in children with congenital and acquired heart disease: an expert consensus paper of the Imaging Working Group of the AEPC and the Cardiovascular Magnetic Resonance Section of the EACVI. Eur Heart J Cardiovasc Imaging. 2015; 16(3): 281-297. Dostupné z DOI: <http://dx.doi.org/10.1093/ehjci/jeu129>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.